Granulocyte Macrophage Colony Stimulating Factor Overview Categories 20 Muscle relaxants and cholinesterase inhibitors Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Deferoxamine Manufacturers of Deferoxamine Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Deferoxamine's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 4 to 32 ug/kg18 (18)24 hourlyIV InfAs Required Paedriatic Dosage (20kg) 1 to 10 ug/kg5.5 (5.5)24 hourlyIntra Venous-1 to 10 ug/kg5.5 (5.5)24 hourlyIV Infusion-1 to 10 ug/kg5.5 (5.5)24 hourlySubcutaneous- Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Deferoxamine is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Deferoxamine Back to top Manufacturers of Granulocyte Macrophage Colony Stimulating Factor in Pakistan Back to top Previous Drug Generic - Next Drug Generic
Granulocyte Macrophage Colony Stimulating Factor Overview Categories 20 Muscle relaxants and cholinesterase inhibitors Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Deferoxamine Manufacturers of Deferoxamine Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Deferoxamine's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 4 to 32 ug/kg18 (18)24 hourlyIV InfAs Required Paedriatic Dosage (20kg) 1 to 10 ug/kg5.5 (5.5)24 hourlyIntra Venous-1 to 10 ug/kg5.5 (5.5)24 hourlyIV Infusion-1 to 10 ug/kg5.5 (5.5)24 hourlySubcutaneous- Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Deferoxamine is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Deferoxamine Back to top Manufacturers of Granulocyte Macrophage Colony Stimulating Factor in Pakistan Back to top Previous Drug Generic - Next Drug Generic